Gastrointestinal lumen toxins and co-administered drugs

Gastrointestinal lumen toxins and co-administered drugs refer to a diverse group of exogenous and endogenous substances located within the digestive tract that are targeted by pharmacological binders or adsorbents. This category encompasses ingested poisons, bacterial enterotoxins (e.g., from Clostridioides difficile or Vibrio cholerae), bile acids, and various pharmaceutical agents that may cause toxicity or require removal from the enterohepatic circulation. These substances are not biological receptors but rather chemical targets for non-absorbable therapeutic agents such as activated charcoal, ion-exchange resins, and polymeric binders [StatPearls, 2023]. By sequestering these molecules within the gut lumen, these therapies prevent their systemic absorption, thereby mitigating toxicity or managing metabolic imbalances like hyperkalemia and hyperphosphatemia [NEJM, 2015]. This mechanism is also utilized to interrupt the enterohepatic circulation of certain drugs and metabolites to accelerate their clearance from the body [PubMed, 2019]. For example, bile acid sequestrants bind bile acids to lower cholesterol or treat diarrhea associated with bile acid malabsorption [Mayo Clinic, 2022]. However, the use of such binders often presents challenges, including non-specific binding of essential nutrients and other co-administered medications, necessitating careful dosing intervals [FDA, 2021]. Overall, targeting luminal substances is a key strategy in emergency toxicology and chronic metabolic management.

Other names

Intestinal toxinsLuminal drugsEnteric toxinsGastrointestinal adsorbatesBile acid sequestrants targets

Physical adsorption, ion exchange, or chemical sequestration within the gastrointestinal lumen to prevent systemic absorption, interrupt enterohepatic circulation, or neutralize local toxic effects.